We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Researchers Explore Why Certain Immunotherapy Patients Develop Lung Inflammation

News   Sep 05, 2019 | Original story from Johns Hopkins Medicine

 
Researchers Explore Why Certain Immunotherapy Patients Develop Lung Inflammation

Credit: Pixabay

 
 
Advertisement
 

RELATED ARTICLES

Janssen COVID-19 Vaccine Issued Emergency Use Authorization by the FDA

News

The U.S. Food and Drug Administration issued an Emergency Use Authorization (EUA) to the Janssen Pharmaceuticals Companies of Johnson & Johnson for its single-shot COVID-19 vaccine, called Ad.26.COV2S or JNJ-78436725.

READ MORE

CD4 T Lymphocytes Shown To Kill Cancer Cells Directly

News

Scientists found that when CD4 T lymphocytes were directly put in close contact with cancer cells, up to a third of them could also kill them.

READ MORE

Neanderthal Protein May Reduce the Severity of COVID-19

News

Researchers at the Lady Davis Institute (LDI) at the Jewish General Hospital have discovered that increased levels of the protein OAS1 are associated with reduced mortality and less severe disease requiring ventilation among patients with COVID-19. Using drugs that boost OAS1 levels could be explored to try to improve these outcomes.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE